Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 4236779
[patent_doc_number] => 06117992
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-12
[patent_title] => 'Reagents and process for synthesis of oligonucleotides containing phosphorodithioate internucleoside linkages'
[patent_app_type] => 1
[patent_app_number] => 8/920087
[patent_app_country] => US
[patent_app_date] => 1997-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4619
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/117/06117992.pdf
[firstpage_image] =>[orig_patent_app_number] => 920087
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/920087 | Reagents and process for synthesis of oligonucleotides containing phosphorodithioate internucleoside linkages | Aug 25, 1997 | Issued |
08/915769 | USE OF URIDINE TO COUNTER 5-FLUOROURACIL TOXICITY | Aug 20, 1997 | Abandoned |
Array
(
[id] => 3790205
[patent_doc_number] => 05840882
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-24
[patent_title] => 'Process for preparing cellulose ethers with recovery of alkali'
[patent_app_type] => 1
[patent_app_number] => 8/911946
[patent_app_country] => US
[patent_app_date] => 1997-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5194
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/840/05840882.pdf
[firstpage_image] =>[orig_patent_app_number] => 911946
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/911946 | Process for preparing cellulose ethers with recovery of alkali | Aug 19, 1997 | Issued |
Array
(
[id] => 3767208
[patent_doc_number] => 05849516
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Semiselective medium composition for detecting seed-borne Alternaria brassicicola'
[patent_app_type] => 1
[patent_app_number] => 8/914836
[patent_app_country] => US
[patent_app_date] => 1997-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1551
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849516.pdf
[firstpage_image] =>[orig_patent_app_number] => 914836
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/914836 | Semiselective medium composition for detecting seed-borne Alternaria brassicicola | Aug 18, 1997 | Issued |
08/875928 | SPECIFIC LIPID CONJUGATES OF NUCLEOSIDE DIPHOSPHATES AND THEIR USE AS PHARMACEUTICAL AGENTS | Aug 12, 1997 | Abandoned |
Array
(
[id] => 3787835
[patent_doc_number] => 05840728
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-24
[patent_title] => 'Conformationally locked nucleoside analogs as antiherpetic agents'
[patent_app_type] => 1
[patent_app_number] => 8/908724
[patent_app_country] => US
[patent_app_date] => 1997-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14324
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/840/05840728.pdf
[firstpage_image] =>[orig_patent_app_number] => 908724
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/908724 | Conformationally locked nucleoside analogs as antiherpetic agents | Aug 6, 1997 | Issued |
Array
(
[id] => 3943495
[patent_doc_number] => 05981734
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Methods for immobilizing nucleic acids on a gel substrate'
[patent_app_type] => 1
[patent_app_number] => 8/895656
[patent_app_country] => US
[patent_app_date] => 1997-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 7568
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/981/05981734.pdf
[firstpage_image] =>[orig_patent_app_number] => 895656
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/895656 | Methods for immobilizing nucleic acids on a gel substrate | Jul 16, 1997 | Issued |
90/004694 | NEURAL CALCIUM-ACTIVATED NEUTRAL PROTEINASE INHIBITORS | Jul 1, 1997 | Issued |
Array
(
[id] => 3811169
[patent_doc_number] => 05811532
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-22
[patent_title] => 'Covalently bound, polysaccharide-based chiral stationary phases'
[patent_app_type] => 1
[patent_app_number] => 8/884835
[patent_app_country] => US
[patent_app_date] => 1997-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4349
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/811/05811532.pdf
[firstpage_image] =>[orig_patent_app_number] => 884835
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/884835 | Covalently bound, polysaccharide-based chiral stationary phases | Jun 29, 1997 | Issued |
Array
(
[id] => 4019447
[patent_doc_number] => 05906997
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-05-25
[patent_title] => 'Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions'
[patent_app_type] => 1
[patent_app_number] => 8/877649
[patent_app_country] => US
[patent_app_date] => 1997-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16769
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/906/05906997.pdf
[firstpage_image] =>[orig_patent_app_number] => 877649
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/877649 | Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions | Jun 16, 1997 | Issued |
Array
(
[id] => 3760961
[patent_doc_number] => 05843909
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-01
[patent_title] => '(3-.beta.), 4-.alpha., 16-.beta.)-16, -23, 28-trihdroxyolean-12-ene-3-yl-.beta.-D-glucopyranuronic acid derivatives, as glucose absorption inhibiting agents'
[patent_app_type] => 1
[patent_app_number] => 8/874675
[patent_app_country] => US
[patent_app_date] => 1997-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10632
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/843/05843909.pdf
[firstpage_image] =>[orig_patent_app_number] => 874675
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/874675 | (3-.beta.), 4-.alpha., 16-.beta.)-16, -23, 28-trihdroxyolean-12-ene-3-yl-.beta.-D-glucopyranuronic acid derivatives, as glucose absorption inhibiting agents | Jun 12, 1997 | Issued |
Array
(
[id] => 3933756
[patent_doc_number] => 05929047
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-27
[patent_title] => 'Anti-viral agent prepared by basic and acidic extraction of mangraves'
[patent_app_type] => 1
[patent_app_number] => 8/809964
[patent_app_country] => US
[patent_app_date] => 1997-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2760
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/929/05929047.pdf
[firstpage_image] =>[orig_patent_app_number] => 809964
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/809964 | Anti-viral agent prepared by basic and acidic extraction of mangraves | Jun 2, 1997 | Issued |
Array
(
[id] => 3810710
[patent_doc_number] => 05854408
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-29
[patent_title] => 'Process for acylating the 1-position of saccharides'
[patent_app_type] => 1
[patent_app_number] => 8/868147
[patent_app_country] => US
[patent_app_date] => 1997-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2387
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/854/05854408.pdf
[firstpage_image] =>[orig_patent_app_number] => 868147
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/868147 | Process for acylating the 1-position of saccharides | Jun 2, 1997 | Issued |
Array
(
[id] => 3817554
[patent_doc_number] => 05789572
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-04
[patent_title] => 'Method for the preparation of 1,4,-anhydro-2-deoxy-d-erythropentitol'
[patent_app_type] => 1
[patent_app_number] => 8/864962
[patent_app_country] => US
[patent_app_date] => 1997-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2813
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/789/05789572.pdf
[firstpage_image] =>[orig_patent_app_number] => 864962
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/864962 | Method for the preparation of 1,4,-anhydro-2-deoxy-d-erythropentitol | May 28, 1997 | Issued |
Array
(
[id] => 3840079
[patent_doc_number] => 05847092
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-08
[patent_title] => 'Erythromycin A 9-0 oxime derivatives endowed with antibiotic activity'
[patent_app_type] => 1
[patent_app_number] => 8/836785
[patent_app_country] => US
[patent_app_date] => 1997-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12623
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/847/05847092.pdf
[firstpage_image] =>[orig_patent_app_number] => 836785
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/836785 | Erythromycin A 9-0 oxime derivatives endowed with antibiotic activity | May 15, 1997 | Issued |
Array
(
[id] => 4043489
[patent_doc_number] => 05874418
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-23
[patent_title] => 'Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use'
[patent_app_type] => 1
[patent_app_number] => 8/851006
[patent_app_country] => US
[patent_app_date] => 1997-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 20
[patent_no_of_words] => 16158
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/874/05874418.pdf
[firstpage_image] =>[orig_patent_app_number] => 851006
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/851006 | Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use | May 4, 1997 | Issued |
Array
(
[id] => 1286848
[patent_doc_number] => 06635442
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-21
[patent_title] => 'Intron/exon structure of the human and mouse 3-adrenergic receptor genes'
[patent_app_type] => B1
[patent_app_number] => 08/848631
[patent_app_country] => US
[patent_app_date] => 1997-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 9865
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/635/06635442.pdf
[firstpage_image] =>[orig_patent_app_number] => 08848631
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/848631 | Intron/exon structure of the human and mouse 3-adrenergic receptor genes | Apr 28, 1997 | Issued |
Array
(
[id] => 3766692
[patent_doc_number] => 05773236
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-30
[patent_title] => 'Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules'
[patent_app_type] => 1
[patent_app_number] => 8/845301
[patent_app_country] => US
[patent_app_date] => 1997-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 22524
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 321
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/773/05773236.pdf
[firstpage_image] =>[orig_patent_app_number] => 845301
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/845301 | Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules | Apr 24, 1997 | Issued |
Array
(
[id] => 3832052
[patent_doc_number] => 05739314
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-14
[patent_title] => 'Method for synthesizing 2\'-O-substituted pyrimidine nucleosides'
[patent_app_type] => 1
[patent_app_number] => 8/846124
[patent_app_country] => US
[patent_app_date] => 1997-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2292
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/739/05739314.pdf
[firstpage_image] =>[orig_patent_app_number] => 846124
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/846124 | Method for synthesizing 2'-O-substituted pyrimidine nucleosides | Apr 24, 1997 | Issued |
Array
(
[id] => 3774936
[patent_doc_number] => 05756704
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-26
[patent_title] => 'Nucleosides and nucleoside derivatives containing enzymatically cleavable protecting groups'
[patent_app_type] => 1
[patent_app_number] => 8/844127
[patent_app_country] => US
[patent_app_date] => 1997-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5130
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/756/05756704.pdf
[firstpage_image] =>[orig_patent_app_number] => 844127
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/844127 | Nucleosides and nucleoside derivatives containing enzymatically cleavable protecting groups | Apr 17, 1997 | Issued |